Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Perinatol. reprod. hum ; 28(3): 129-133, jul.-sep. 2014. tab
Artigo em Espanhol | LILACS | ID: lil-744092

RESUMO

En los neonatos en estado crítico es necesario establecer un sistema de farmacovigilancia con el cual se les proteja de posibles reacciones adversas a los medicamentos; estas reacciones pueden ser por el efecto farmacológico, la interacción con otros medicamentos, errores de dosificación y la idiosincrasia del paciente, de acuerdo con la Norma Oficial Mexicana 220. Objetivo: Conocer el estado actual de la farmacovigilancia en unidades de cuidado intensivo neonatal del estado de Jalisco. Material y métodos: Mediante un cuestionario estructurado de 12 preguntas, se practicó una encuesta de opinión en referencia a los programas de farmacovigilancia en los recién nacidos en estado crítico en instituciones del área metropolitana de Guadalajara y el interior del estado de Jalisco. Se aplicó en ocho centros hospitalarios que cuentan con terapia intensiva neonatal y en un congreso estatal de pediatría en el año 2011. A todos los participantes se les pidió que de manera voluntaria, llenaran una documento ad hoc; los resultados se procesaron en el programa Epi info 2010. Discusión y conclusiones: Los resultados demuestran que no se está cumpliendo la NOM 220. Existe un gran déficit de unidades con programas implementados de farmacovigilancia y proceso de notificación de reacciones adversas a medicamentos; la cobertura es menor al 50%. Al parecer, el problema es aún mayor en instituciones particulares. Es necesario cumplir con la NOM 220 para asegurar la calidad de atención en los recién nacidos críticos en el estado de Jalisco.


There is a need to establish medication surveillance/monitoring systemsfor newborn patients in critical condition in order to protect these patients from possible adverse reactions to prescribed drugs. In accordance with Mexican official standard NOM 220, these reactions may result from pharmacological effects, interaction with other drugs, dosage errors, and the patient's nature/idiosyncrasy. Objective: Our goal was to gain knowledge on the current situation regarding medication surveillance in neonatal intensive care units within the state of Jalisco. Material and methods: By means of a structured questionnaire involving 12 questions, an opinion poll was carried out with reference to medication surveillance programs for newborn patients in critical condition at institutions within Guadalajara's metropolitan area and the State of Jalisco. The survey was conducted in 8 hospital centers that provide neonatal intensive care and at a state congress on pediatrics that took place in 2011. All of the respondents were asked to voluntarily fill out a questionnaire Ad-hoc, and the results were processed using the Epi Info 2010 program. Discussion and conclusions: The results show that there is widespread noncompliance of NOM 220. There is a considerable deficit with respect to units implementing medication surveillance systems and methods to notify adverse reactions to medication, with implementation rates lower than 50%. It appears that the problem is even greater in private institutions. Compliance with NOM 220 is essential in order to guarantee the quality of the care provided to newborn patients in critical condition within the state of Jalisco.

2.
Ginecol Obstet Mex ; 82(7): 441-7, 2014 Jul.
Artigo em Espanhol | MEDLINE | ID: mdl-25102669

RESUMO

BACKGROUND: Pregnancy in women addicted represents, in itself, a major risk of destruction of physical and mental health of the unborn child; urgent prevention is the same as essential to providing quality care to the mother and child knowledge. OBJECTIVE: Describe the physical and sociodemographic characteristics of neonates in intensive care units, born of mothers with addictions. MATERIALS AND METHOD: Cross-sectional, descriptive study of neonates with addict mothers, analyzing age, gender, clinical symptoms and complications. Findings for frequency-percentages with regard to qualitative variables, and medians and ranges for quantitative variables. SPSS-20.0-Windows Statistics software package. RESULTS: 618 patients admitted to the NICU, 180(29%) showing withdrawal symptoms; irritability in 117 (63%), intensive crying in 93 (51%), spontaneous Moro reflex 74 (42%), diarrhea 61 (30%), fever 61 (30%). Birth defects 124 (20%), from greater to lesser occurrence: disorders in central nervous system, digestive tract and abdominal wall, extremities, kidneys, and others. 309 (50%) weight lower than 2600g. The most frequent metabolic disorders were hypoglycemia, Metabolic Acidosis and jaundice, among others. CONCLUSIONS: Every day, we see more children born of substance-dependent mothers in the Mexico. Our study reveals high mortality rate and many complications for this group; thus, it becomes necessary to institute preventive measures among Mexican women of childbearing age in order to prevent illegal drug use and to increase treatment among pregnant addicts. Gynecologists, pediatricians and neonatologists must have extensive knowledge regarding the entire clinical-social spectrum of symptoms that may be observed in children of mothers suffering addictions.


Assuntos
Filho de Pais com Deficiência , Anormalidades Congênitas/epidemiologia , Mães , Transtornos Relacionados ao Uso de Substâncias , Estudos Transversais , Feminino , Humanos , Recém-Nascido , Unidades de Terapia Intensiva Neonatal , Masculino , México , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...